The Antiviral activities of the cationic host defence peptide LL-37 against Rhinovirus
  A pump-priming proposal designed to investigate the potential for LL-37, a human cationic host defence peptide, to inhibit Rhinovirus infection and/or target cells infected with Rhinovirus for induction of apoptotic cell death

  • Start Date:

    1 February 2013

  • End Date:

    12 November 2014

  • Activity Type:

    Externally Funded Research

  • Funder:

    Tenovus Scotland

  • Value:


Project Team